Botanical species · safety record

Tilia platyphyllos

The EFSA Compendium of Botanicals holds 4 constituent measurements and 1 adverse-effect record for Tilia platyphyllos. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Tilia platyphyllos Scop.

4Constituent measurements

1Safety records

3Cited sources

20Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 20 licensed products naming Tilia platyphyllos as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Flower
New material

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Carvone	Flower	Essential oil	6 Percent	GC-MS	No resolvable identifier
Dihydrocarvone	Flower	Essential oil	29 Percent	GC-MS	No resolvable identifier
Eugenol	Flowering top	Essential oil	2.43 Percent	GC-MS	No resolvable identifier
Methyleugenol	Flowering top	Essential oil	1.27 Percent	GC-MS	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive: pancreas	Aerial part of plants	Solvent extraction	—	In vitro	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Slanc, Petra., Doljak, Bojan., Kreft, Samo., Lunder, Mojca., Janes, Damjan., Strukelj, Borut. Screening of Selected Food and Medicinal Plant Extracts for Pancreatic Lipase Inhibition . Phytotherapy research, 2009, vol. 23, no. 6, p. 874-877. DOI
Radulescu, V., Oprea, E. Analysis of volatile compounds of officinal Tiliae flos by gas - Chromatography coupled with mass spectrometry. Farmacia, 2008, vol. 56, no. 2, p. 129-138.
Ahmadi, L., Mirza, M. Volatile constituents of Tilia platyphyllos Scop. Flowers. Journal of essential oil research, 1999, vol. 11, no. 6, p. 765-766.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature